Works matching IS 13419625 AND DT 2020 AND VI 25 AND IP 9

Results: 22

Correction to: Results of a phase II trial for high-risk neuroblastoma treatment protocol JN-H-07: a report from the Japan Childhood Cancer Group Neuroblastoma Committee (JNBSG).

Published in:

2020

By:

Hishiki, Tomoro;
Matsumoto, Kimikazu;
Ohira, Miki;
Kamijo, Takehiko;
Shichino, Hiroyuki;
Kuroda, Tatsuo;
Yoneda, Akihiro;
Soejima, Toshinori;
Nakazawa, Atsuko;
Takimoto, Tetsuya;
Yokota, Isao;
Teramukai, Satoshi;
Takahashi, Hideto;
Fukushima, Takashi;
Kaneko, Takashi;
Hara, Junichi;
Kaneko, Michio;
Ikeda, Hitoshi;
Tajiri, Tatsuro;
Nakagawara, Akira

Publication type:

Correction Notice

Neo-adjuvant chemotherapy alone for the locally advanced rectal cancer: a systematic review.

Published in:

International Journal of Clinical Oncology, 2020, v. 25, n. 9, p. 1570, doi. 10.1007/s10147-020-01738-2

By:

Manatakis, Dimitrios K.;
Gouvas, Nikolaos;
Souglakos, John;
Xynos, Evangelos

Publication type:

Article

Role of the DEK oncogene in the development of squamous cell carcinoma.

Published in:

International Journal of Clinical Oncology, 2020, v. 25, n. 9, p. 1563, doi. 10.1007/s10147-020-01735-5

By:

Ishida, Kazuhisa;
Nakashima, Takayuki;
Shibata, Toshiyuki;
Hara, Akira;
Tomita, Hiroyuki

Publication type:

Article

Evaluation of COVID 19 infection in 279 cancer patients treated during a 90-day period in 2020 pandemic.

Published in:

International Journal of Clinical Oncology, 2020, v. 25, n. 9, p. 1581, doi. 10.1007/s10147-020-01734-6

By:

Aznab, Mozaffar

Publication type:

Article

Novel classification of ovarian metastases originating from colorectal cancer by radiological imaging and macroscopic appearance.

Published in:

International Journal of Clinical Oncology, 2020, v. 25, n. 9, p. 1663, doi. 10.1007/s10147-020-01717-7

By:

Kato, Mayumi Kobayashi;
Shida, Dai;
Yoneoka, Yutaka;
Yoshida, Hiroshi;
Miyasaka, Naoyuki;
Kanemitsu, Yukihide;
Kato, Tomoyasu

Publication type:

Article

Predicting factors for progression to castration resistance prostate cancer after biochemical recurrence in patients with clinically localized prostate cancer who underwent radical prostatectomy.

Published in:

International Journal of Clinical Oncology, 2020, v. 25, n. 9, p. 1704, doi. 10.1007/s10147-020-01716-8

By:

Hashimoto, Takeshi;
Nakashima, Jun;
Kashima, Takeshi;
Yamaguchi, Yuri;
Satake, Naoya;
Nakagami, Yoshihiro;
Namiki, Kazunori;
Ohno, Yoshio

Publication type:

Article

Association between chronic kidney disease and mortality in stage IV cancer.

Published in:

International Journal of Clinical Oncology, 2020, v. 25, n. 9, p. 1587, doi. 10.1007/s10147-020-01715-9

By:

Ishii, Taisuke;
Fujimaru, Takuya;
Nakano, Eriko;
Takahashi, Osamu;
Nakayama, Masaaki;
Yamauchi, Teruo;
Komatsu, Yasuhiro

Publication type:

Article

Aggressive surgery for advanced ovarian cancer decreases the risk of intraperitoneal recurrence.

Published in:

International Journal of Clinical Oncology, 2020, v. 25, n. 9, p. 1726, doi. 10.1007/s10147-020-01714-w

By:

Tate, Shinichi;
Nishikimi, Kyoko;
Matsuoka, Ayumu;
Shozu, Makio

Publication type:

Article

Predictive factors of rectal hemorrhage in patients with localized prostate cancer who underwent low-dose-rate brachytherapy.

Published in:

International Journal of Clinical Oncology, 2020, v. 25, n. 9, p. 1711, doi. 10.1007/s10147-020-01713-x

By:

Taniguchi, Tomoki;
Iinuma, Koji;
Kato, Daiki;
Takai, Manabu;
Maekawa, Yuka Muramatsu;
Nakane, Keita;
Mizutani, Kosuke;
Tsuchiya, Tomohiro;
Nakano, Masahiro;
Kato, Taku;
Ito, Masaya;
Kumano, Tomoyasu;
Matsuo, Masayuki;
Koie, Takuya

Publication type:

Article

Blood platelet volume predicts treatment-specific outcomes of metastatic castration-resistant prostate cancer.

Published in:

International Journal of Clinical Oncology, 2020, v. 25, n. 9, p. 1695, doi. 10.1007/s10147-020-01712-y

By:

Fukuokaya, Wataru;
Kimura, Takahiro;
Urabe, Fumihiko;
Kimura, Shoji;
Tashiro, Kojiro;
Tsuzuki, Shunsuke;
Koike, Yusuke;
Sasaki, Hiroshi;
Miki, Kenta;
Egawa, Shin

Publication type:

Article

Comparison of S-1–cisplatin every 5 weeks with capecitabine-cisplatin every 3 weeks for HER2-negative gastric cancer (recurrent after S-1 adjuvant therapy or chemotherapy-naïve advanced): pooled analysis of HERBIS-2 (OGSG 1103) and HERBIS-4A (OGSG 1105) trials

Published in:

International Journal of Clinical Oncology, 2020, v. 25, n. 9, p. 1635, doi. 10.1007/s10147-020-01711-z

By:

Kawakami, Hisato;
Fujitani, Kazumasa;
Matsuyama, Jin;
Akamaru, Yusuke;
Tamura, Shigeyuki;
Endo, Shunji;
Kimura, Yutaka;
Makari, Youichi;
Tamura, Takao;
Sugimoto, Naotoshi;
Sakai, Daisuke;
Tsujinaka, Toshimasa;
Goto, Masahiro;
Kurokawa, Yukinori;
Shimokawa, Toshio;
Satoh, Taroh

Publication type:

Article

Usefulness of fluorescence visualization-guided surgery for early-stage tongue squamous cell carcinoma compared to iodine vital staining.

Published in:

International Journal of Clinical Oncology, 2020, v. 25, n. 9, p. 1604, doi. 10.1007/s10147-020-01710-0

By:

Ikeda, Yusuke;
Suzuki, Taiki;
Saitou, Hirokazu;
Ogane, Satoru;
Hashimoto, Kazuhiko;
Takano, Nobuo;
Nomura, Takeshi

Publication type:

Article

Impact of centralization in primary retroperitoneal sarcoma treatment: analysis using hospital-based cancer registry data in Japan.

Published in:

International Journal of Clinical Oncology, 2020, v. 25, n. 9, p. 1687, doi. 10.1007/s10147-020-01709-7

By:

Kimura, Tomokazu;
Kawai, Koji;
Kandori, Shuya;
Nitta, Satoshi;
Kojo, Kosuke;
Nagumo, Yoshiyuki;
Negoro, Hiromitsu;
Okuyama, Ayako;
Higashi, Takahiro;
Kojima, Takahiro;
Nishiyama, Hiroyuki

Publication type:

Article

Clinical outcomes of second-line treatment following prior targeted therapy in patients with metastatic renal cell carcinoma: a comparison of axitinib and nivolumab.

Published in:

International Journal of Clinical Oncology, 2020, v. 25, n. 9, p. 1678, doi. 10.1007/s10147-020-01708-8

By:

Suzuki, Kotaro;
Terakawa, Tomoaki;
Furukawa, Junya;
Harada, Kenichi;
Hinata, Nobuyuki;
Nakano, Yuzo;
Fujisawa, Masato

Publication type:

Article

The efficacy and toxicity of metronomic oral vinorelbine monotherapy in patients with non-small cell lung cancer: a meta-analysis.

Published in:

International Journal of Clinical Oncology, 2020, v. 25, n. 9, p. 1624, doi. 10.1007/s10147-020-01707-9

By:

Xu, Ke;
Liu, Tao;
Zhang, Jie;
Zhou, Yangang;
Yang, Fang;
Ren, Tao

Publication type:

Article

Suppressive effect upon carboplatin hypersensitivity reaction via pegylated liposomal doxorubicin combination therapy.

Published in:

International Journal of Clinical Oncology, 2020, v. 25, n. 9, p. 1718, doi. 10.1007/s10147-020-01706-w

By:

Shimada, Kyoko;
Nagao, Shoji;
Suzuki, Kazuhiro;
Shibutani, Takashi;
Yamamoto, Kasumi;
Jimi, Tomoatsu;
Yano, Hiroko;
Kitai, Miho;
Shiozaki, Takaya;
Yamaguchi, Satoshi

Publication type:

Article

Chemoradiotherapy for high-risk stage II laryngeal cancer.

Published in:

International Journal of Clinical Oncology, 2020, v. 25, n. 9, p. 1596, doi. 10.1007/s10147-020-01705-x

By:

Hamauchi, Satoshi;
Yokota, Tomoya;
Onozawa, Yusuke;
Ogawa, Hirofumi;
Onoe, Tsuyoshi;
Kamijo, Tomoyuki;
Iida, Yoshiyuki;
Onitsuka, Tetsuro;
Yasui, Hirofumi

Publication type:

Article

Risk factors for metachronous colorectal cancer in Lynch syndrome patients: a registry-based observational mono-institutional study cohort.

Published in:

International Journal of Clinical Oncology, 2020, v. 25, n. 9, p. 1644, doi. 10.1007/s10147-020-01700-2

By:

Signoroni, Stefano;
Piozzi, Guglielmo Niccolò;
Ricci, Maria Teresa;
Mancini, Andrea;
Morabito, Alberto;
Bertario, Lucio;
Vitellaro, Marco

Publication type:

Article

Efficacy and safety of tisagenlecleucel in Japanese adult patients with relapsed/refractory diffuse large B-cell lymphoma.

Published in:

International Journal of Clinical Oncology, 2020, v. 25, n. 9, p. 1736, doi. 10.1007/s10147-020-01699-6

By:

Goto, Hideki;
Makita, Shinichi;
Kato, Koji;
Tokushige, Kota;
Fujita, Taizo;
Akashi, Koichi;
Izutsu, Koji;
Teshima, Takanori

Publication type:

Article

Effect of early adverse events resulting in sorafenib dose adjustments on survival outcomes of advanced hepatocellular carcinoma patients.

Published in:

International Journal of Clinical Oncology, 2020, v. 25, n. 9, p. 1672, doi. 10.1007/s10147-020-01698-7

By:

Ruanglertboon, Warit;
Sorich, Michael J.;
Rowland, Andrew;
Hopkins, Ashley M.

Publication type:

Article

Signet ring cell component in pretreatment biopsy predicts pathological response to preoperative chemoradiotherapy in rectal cancer.

Published in:

International Journal of Clinical Oncology, 2020, v. 25, n. 9, p. 1653, doi. 10.1007/s10147-020-01697-8

By:

Chao, Xue;
Wang, Zixian;
Lu, Shixun;
Huang, Yuhua;
Zang, Shengbing;
Ding, Peirong;
Zhang, Huizhong;
Yun, Jingping

Publication type:

Article

FAM83A drives PD-L1 expression via ERK signaling and FAM83A/PD-L1 co-expression correlates with poor prognosis in lung adenocarcinoma.

Published in:

International Journal of Clinical Oncology, 2020, v. 25, n. 9, p. 1612, doi. 10.1007/s10147-020-01696-9

By:

Zhou, Fengrui;
Wang, Xin;
Liu, Fang;
Meng, Qingwei;
Yu, Yan

Publication type:

Article